105
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Decomposing the effect of drug benefit program on antihypertensive medication adherence among the elderly in urban China

, , , , , & show all
Pages 1111-1123 | Published online: 11 Jul 2019

References

  • Olsen MH, Angell SY, Asma S, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet commission on hypertension. Lancet. 2016;388:2665–2712. doi:10.1016/S0140-6736(16)31134-527671667
  • Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390(10112):2549–2558. doi:10.1016/S0140-6736(17)32478-929102084
  • Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(18):487–497. doi:10.1056/NEJMra05010016079372
  • Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood). 2003;22(4):220–229. doi:10.1377/hlthaff.22.4.22012889771
  • Wang Y. Investigation and Prevention on Chronic Disease in China. Beijing: China Social Sciences Press; 2011:39–40.
  • Zhong H. Effect of patient reimbursement method on health-care utilization: evidence from China. Health Econ. 2011;1312–1329. doi:10.1002/hec.167020882574
  • Zhang WJ. The Research of the Urban Employee Medical Insurance for Outpatient Health Service. Nanjing, Jiangsu, China: Southest University Press; 2016:6–12.
  • Xinjiang Production and Construction Corps thirteenth division of government affairs network. Medical insurance policy guide. Available from: http://www.btnsss.gov.cn/gk/yewugongzuo/bdw/22109.htm. Accessed 3 2, 2018.
  • The Six Division of Wujiaqu City. Document on the uniform policy of the implementation corps of medical insurance policy of divison and city. Available from: http://www.wjq.gov.cn/xxbssg/100678.htm. Accessed 32, 2018.
  • Shihezi City of Xinjiang. Document on the identification and application of drug benefit program in the urban employees basic medical insurance in 2015. Available from: http://www.shz.gov.cn/structure/newSite/New_Channel_1/New_Page_2?infid=2558. Accessed 32, 2018.
  • Chernew ME, Shah MR, Wegh A, et al. Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff. 2008;27(1):103–112. doi:10.1377/hlthaff.27.1.103
  • Yu B, Zhang X, Wang G. Full coverage for hypertension drugs in rural communities in China. Am J Manag Care. 2013;19(1):e22–e9.23379776
  • Maimaris W, Paty J, Perel P, et al. The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med. 2013;10(7):e1001490. doi:10.1371/journal.pmed.100149023935461
  • Zhang YJ, Li XJ, Mao L, et al. Factors affecting medication adherence in community-managed patients with hypertension based on the principal component analysis: evisence from Xinjiang, China. Patient Prefer Adherence. 2018;5(12):803–812. doi:10.2147/PPA.S158662
  • Doll JA, Hellkamp AS, Goyal A, Sutton NR, Peterson ED, Wang TY. Treatment, outcomes, and adherence to medication regimens among dual Medicare-Medicaid-eligible adults with myocardial infarction. JAMA Cardiol. 2016;1(7):787–794. doi:10.1001/jamacardio.2016.272427541822
  • Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598–1605. doi:10.1161/CIRCULATIONAHA.108.83029919805653
  • Bandi P, Goldmann E, Parikh NS, Farsi P, Bodenalbala B. Age-related differences in antihypertensive medication adherence in Hispanics: a cross-sectional community-based survey in New York city, 2011–2012. Prev Chronic Dis. 2017;14:E57. doi:10.5888/pcd14.16051228704175
  • Cho MH, Yoo KB, Lee HY, et al. The effect of new drug pricing systems and new reimbursement guidelines on pharmaceutical expenditures and prescribing behavior among hypertensive patients in Korea. Health Policy. 2015;119(5):604–611. doi:10.1016/j.healthpol.2015.01.00225630635
  • Ye XQ, Lin FY, Chen WQ. Study on influence factoes of compliance to antihypertensive medications. Mod Preventive Med. 2007;34(3):494–496.
  • Ye XQ, Liu YL, Chen WQ. Knowledge, health beliefs in hypertensive patients and its influence on durg compliance. Chin J Nurs. 1998;33(11):624–626.
  • Aday LA, Andersen R. A framework for the study of access to medical care. Health Serv Res. 1974;9(3):208–220.4436074
  • Mekonnen HS, Gebrie MH, Eyasu KH, et al. Drug adherence for antihypertensive medications and its determinants among adult hypertensive patients attending in chronic clinics of referral hospitals in Northwest Ethiopia. BMC Pharmacol Toxicol. 2017;18(1):27. doi:10.1186/s40360-017-0134-928381241
  • Blinder AS. Wage discrimination: reduced form and structural estimates. J Hum Resour. 1973;8(4):436–455. doi:10.2307/144855
  • Oaxaca R. Male-Female wage differentials in urban labor markets. Int Econ Rev (Philadelphia). 1973;14(3):693–709. doi:10.2307/2525981
  • Yun MS, Powers DA, Yoshioka H. Mvdcmp: multivariate decomposition for nonlinear response models. Stata J. 2012;11(4):556–576.
  • De Geest S, Sabaté E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs. 2003;323. doi:10.1016/S1474-5151(03)00091-414667488
  • Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19(11):1190–1196. doi:10.1016/j.amjhyper.2006.04.00617070434
  • Zhang JX, Yin W, Sun SX, et al. The impact of the Medicare Part D prescription benefit on generic drug use. J Gen Intern Med. 2008;23(10):1673–1678. doi:10.1007/s11606-008-0742-618661190
  • Davidoff AJ, Stuart BT, Shoemaker JS, et al. Lessons learned: who didn’t enroll in Medicare drug coverage in 2006, and why? Health Aff. 2010;29(6):1255–1263. doi:10.1377/hlthaff.2009.0002
  • Duru OK, Edgington S, Mangione C, et al. Association of Medicare Part D low-income cost subsidy program enrollment with increased fill adherence to clopidogrel after coronary stent placement. Pharmacotherapy. 2014;34(12):1230–1238. doi:10.1002/phar.150225314343
  • Wei LL, Lloyd JT, Shrank WH. The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D. J Am Geriatr Soc. 2013;61(8):1315–1323. doi:10.1111/jgs.1236423889465
  • Yala SM, Duru O, Ettner SL, et al. Patterns of prescription drug expenditures and medication adherence among Medicare Part D beneficiaries with and without the low-income supplement. BMC Health Serv Res. 2014;14:665. doi:10.1186/s12913-014-0665-325526892
  • Kun YU, Cao J, Hua FU. Analysis of factors affecting physicians’ prescribing conduct. Chin J Hosp Admin. 2002;18:92–94.
  • Chu HL, Liu SZ, Romeis JC. Assessing the effects of drug price reduction policies on older people in Taiwan. Health Serv Manage Res. 2011;24(1):1–7. doi:10.1258/hsmr.2010.01001621285360
  • Tran BX, Hwang J, Nguyen LH, et al. Cost-Related medication nonadherence and cost-saving behaviors among patients with glaucoma before and after the implementation of Medicare part D. JAMA Ophthalmol. 2015;133(9):985–996. doi:10.1001/jamaophthalmol.2015.167126042393
  • O’Donnell O, Doorslaer EV, Wagstaff A, et al. Analyzing Health Equity Using Household Survey Data: A Guide to Techniques and Their Implementation. The World Bank;2008:147–156. Available from: http://web.worldbank.org/archive/website01411/WEB/IMAGES/HEALTHEQ.PDF. Accessed July 3, 2019.
  • Basu S, Hong A, Siddiqi A. Using decomposition analysis to identify modifiable racial disparities in the distribution of blood pressure in the United States. Am J Epidemiol. 2015;182(4):345–353. doi:10.1093/aje/kwv07926199379
  • Mortensen K, Song PH. Minding the gap: a secomposition of emergency department use by Medicaid enrollees and the uninsured. Med Care. 2008;46(10):1099–1107. doi:10.1097/MLR.0b013e318185c92d18815532
  • Saito E, Gilmour S, Yoneoka D, et al. Inequality and inequity in healthcare utilization in urban Nepal: a cross-sectional observational study. Health Policy Plan. 2016;31(7):817–824. doi:10.1093/heapol/czv13726856362
  • Brekke L, Buysman E, Grabner M, et al. The use of decomposition methods in real-world treatment benefits evaluation for patients with type 2 diabetes initiating different injectable therapies: findings from the INITIATOR study. Value Health. 2017;20(10):1252–1259. doi:10.1016/j.jval.2017.05.01929241884
  • Jiang Y, Ni W. Estimating the impact of adherence to and persistence with atypical antipsychotic therapy on health care costs and risk of hospitalization. Pharmacotherapy. 2015;35(9):813–822. doi:10.1002/phar.163426406773
  • Qin J, Wang J, Zhu D Analysis report of health services survey of Xinjiang production and construction corps, 2010. Xinjiang Production and Construction Corps Press; 2013:68–69.
  • The Cebsus Office of the State Council. Tabulation on the 2010 Population Census of the People’s Republic of China. Beijing: China Statistics Press; 2012:51–55.